John Gu

John Gu serves as Chief Executive Officer at Crown Bioscience, Inc.. Crown Bioscience, Inc. operates in the research sector with approximately 580.0 employees. The company is headquartered in Woodbridge, Connecticut. Crown Bioscience, Inc. generates annual revenue of 200000000.0. To date, Crown Bioscience, Inc. has raised 63782176.0 in total funding, with the most recent round being Series D.

Industry & Role Insights

• • MessageCEO tracks 2,961 executives in the research sector.
• • We have verified contacts for 2 executives at Crown Bioscience, Inc..
• • 612 executive contacts are available in Connecticut.
• • Our database includes 201,469 c suite-level executives.

Salesforce Rackspace MailGun Outlook Sendgrid Microsoft Office 365 VueJS Media Temple SSL WP Engine AWS SDK for JavaScript Drift React Mapbox Hubspot Amazon SES DoubleClick Conversion Mobile Friendly 33Across DoubleClick Linkedin Login Bootstrap Framework Workday Recruit Google Dynamic Remarketing Facebook Widget Facebook Custom Audiences AdRoll LeadForensics Linkedin Marketing Solutions Shutterstock Twitter Advertising Eventbrite Google Tag Manager Linkedin Widget Facebook Login (Connect) Highcharts JS Library Google AdSense Google Analytics Hotjar Lucky Orange AI

biomarker discovery validated xenograft models cancer cell based assays huprime pdx models immunotherapy platforms drug development oncology drug development organoids oncology biotechnology life sciences biotechnology research contract research organization cro oncology research immuno-oncology preclinical models patient-derived xenograft pdx humanized tumor models organoid technology clinical trial support in vivo imaging high content imaging multi-omics analysis drug resistance cell line authentication biological samples proteomics genomics data science bioinformatics ex vivo testing customer satisfaction biomedical research efficacy testing translational research mouse models pharmacology immunotherapy customized solutions biopharma partnerships companion diagnostics target validation bioanalysis services safety pharmacology translational biomarkers patient tissue analysis flow cytometry liquid biopsy rna sequencing crispr technology genetic profiling custom assay development orthotopic models drug efficacy biotechnology services research & innovation drug discovery preclinical research patient-derived xenograft models cell line-derived xenograft models tumor organoids biomarker analysis bioanalysis oncology databases pharmaceutical industry biopharmaceuticals in vivo models in vitro models ex vivo models in silico models cancer research scientific innovation quality standards global operations research services cancer model database therapeutic efficacy drug candidates clinical trials patient-centric outcomes advanced technologies collaboration biospecimen solutions iso accreditation client service excellence hospital & health care information technology & services health care health wellness & fitness

SN

Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.

SD

Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.

M

Mark Chief Executive Officer at 23Strands

IT

Ilia Tikhomirov Chief Executive Officer at 35Pharma

AD

Alistair Draffan Chief Executive Officer at 360biolabs Pty Ltd

How can I contact John Gu?

John Gu's verified email address is available on MessageCEO. They currently work at Crown Bioscience, Inc.. Pro subscribers can access direct email addresses for over 200,000 executives.

What company does John Gu lead?

John Gu is Chief Executive Officer at Crown Bioscience, Inc., a company in the research sector with 580.0 employees. The company is based in Woodbridge, Connecticut.

What industry is John Gu in?

John Gu works in the research industry as Chief Executive Officer at Crown Bioscience, Inc.. MessageCEO provides verified contact information for executives across all major industries.

Is John Gu's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. John Gu's profile is kept up-to-date with the latest available information.

Last updated: April 13, 2026